mCRPC in focus
Transcript: ESMO and NCCN guideline recommendations for mCRPC
Professor Axel Merseburger
All transcripts are created from interview footage and directly reflect the content of the interview at the time. The content is that of the speaker and is not adjusted by Medthority.
So, clinical practice guideline recommendation for metastatic castration-resistant prostate cancer, we have a lot of guidelines, which are highly respected, and good for everyday clinical use; namely, the NCCN or ESMO EAU Guidelines, Which are on a regular basis updated, and guide us to treat men with metastatic castration-resistant prostate cancer.
However, it's not always easy, since we have different patient profiles. Some refuse, for example, chemotherapy. Some asking for novel therapies like theranostics. Some just want to have basic ADT hormone treatment.
So. it's really something you need to discuss with your patient. And, this is what we do and a lot of colleagues also do, to talk, and to educate, and inform the patients on the options we have on metastatic castration-resistant prostate cancer. In summary, the recommendation is to give ADT as backbone treatment lifelong in mCRPC. And then, add on whatever makes sense and whatever is approved in the local healthcare system and reimbursed. And, this taken together, we have a large armamentarium of drugs from hormone treatment, from novel hormone treatments, up to chemotherapy, and recent developments in theranostics, and also immune therapy, which are on the horizon, and in some countries, already approved. So, we have a lot of treatments for this deadly disease, and that have proven to prolong the overall survival of those men with this deadly disease.
Updates in your area
of interest
of interest
Articles your peers
are looking at
are looking at
Bookmarks
saved
saved
Days to your
next event
next event
Developed by EPG Health. This content has been developed independently of the sponsor, Pfizer, which has had no editorial input into the content. EPG Health received funding from the sponsor to help provide healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content. This content is intended for healthcare professionals only.